Skip to content

Advances in Motion provides health care professionals with information about the latest breakthroughs, research and clinical advances from Massachusetts General Hospital.

Featured In Oncology

Could altering the balance between two CD8+ T cell states enhance immunotherapies? Research from the Massachusetts General Hospital Cancer Center seeks to find the answer.

Featured In Neuroscience

Massachusetts General Hospital and McClean Hospital researchers take significant steps towards proving the safety and efficacy of dopaminergic neuron implantation to treat Parkinson's disease.

Featured In Research and Innovation

Pegylated interferon lambda (PEG-IFN-lambda) is a potent antiviral cytokine that acts to generate an antiviral state within many cell types. In this Q&A, Raymond Chung, MD, explains what is currently known about PEG-IFN-lambda therapy and why he is excited about its potential to treat COVID-19 patients.

Featured In OB/GYN

Massachusetts General Hospital physicians suggest that if COVID-19 in pregnant women is not improved by treatment, then delivery may be considered even in the absence of obstetric indications.

Featured In Neuroscience

Patients are opting not to seek medical care due to fears of COVID-19. Massachusetts General Hospital has prepared for this pandemic and taken every precaution to accept stroke patients in the emergency department. Researchers are identifying the links between infection and stroke risk.

The Latest Cancer Center Advances

The DNA deaminases contained in CRISPR-Cas cytosine and adenine base editors can induce extensive edits in RNA—and researchers at the Massachusetts General Hospital Cancer Center have engineered improved editors that substantially reduce these unwanted effects.

Could altering the balance between two CD8+ T cell states enhance immunotherapies? Research from the Massachusetts General Hospital Cancer Center seeks to find the answer.

Contributing Physicians

Professor of Pathology, Harvard Medical School, Center for Cancer Research, Desmond and Ann Heathwood MGH Research Scholar

Dr. Joung

Director, MGH Center for Cancer Immunology
Center for Cancer Research , Professor of Medicine, Harvard Medical School, Senior Member, Broad Institute

Dr. Hacohen

Advances Specialties


In women with a horseshoe kidney, preoperative imaging is important to determine whether surgery involving presacral dissection is safe or even feasible.

Research and Innovation

According to Massachusetts Hospital researchers, the degree of abnormality on computed tomography in COVID-19 bears no consistent relationship to respiratory system mechanics.


Research led by Brian Eisner, MD, co-director of the Kidney Stone Program at Massachusetts General Hospital, shows no risk of ureteral lesions with the use of ureteral access sheaths four years post-procedure.

Education & Training Opportunities

May 29, 2020

This one-day course is dedicated to educating front line caregivers with up-to-date diagnosis and management of women with cardiovascular conditions including during pregnancy, women with coronary artery dissection, microvascular disease and myocardial infarction with nonobstructive coronary arteries (MINOCA). In addition, guidance and strategies on the development of women heart centers and cardio-obstetric programs will be provided.

Clinical Trials

In Neuroscience

If you are a mother who has experienced an episode of postpartum psychosis within the past ten years, you could help us to better understand this serious disorder.

In Cardiovascular

We are currently recruiting HIV + adults who are interested in participating in a study assessing heart health through new, noninvasive ways of looking at the heart vessels through imaging.